Articles

Shares ticked up premarket as the company says it plans to return $9 billion to shareholders through dividends and stock buybacks in 2024.

Cardinal Health’s shares fell premarket Thursday after the company reported mixed quarterly results but raised its full-year profit outlook.

Executives in the know aren’t biting at discounted share prices.

Barry McCarthy is stepping down as Peloton’s CEO, the connected-fitness company announced on Thursday morning.

The MainStay Winslow Large Cap Growth fund owes a lot of its returns to Big Tech. Co-portfolio manager Justin Kelly is hot on the hunt for new winners. Here are some ideas.

Whatever your age, you need to invest more in your future to ensure you age well.

If the property has been held for a long time things can become complicated.

Here’s the key that could unlock the U.S. housing market for buyers and sellers.

Novartis on Thursday said it will pay up to $1.75 billion for a U.S. biotech focused on cancer.

Tech giants’ recent earnings reveal a clear winner in market leadership and momentum.

Deliberately weakening social protections has created greater financial and economic insecurity.

Regeneron Pharmaceuticals’ stock fell 2.6% premarket Thursday, after the drug company’s first-quarter profit and revenue fell short of analyst estimates.